Delivery Order SPE2DB22D2108-SPE2DB24FU3FU
- Not listed
- The federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pen medication, valued at $1,993.76, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $2,253.38 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor supporting the U.S. government. The contract has an ultimate completion date of May 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pens, valued at $1,387.68. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 7, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies,...
- This federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to support federal healthcare programs. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 1, 2024, with a ceiling value of $1,714.88 and an ultimate completion date of April 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- The federal contract award detailed is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $6,963.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with a completion date of November 13, 2024. This delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical that provides a wide range of...
- This contract award is for $1,738.54 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Mounjaro 7.5 mg/0.5 ml pens. The contract is a firm fixed-price Delivery Order with a completion date of February 27, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $3,948.18 and an ultimate completion date of December 19, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,030.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price and a completion date of May 18, 2023. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of Mounjaro 15 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a defense agency. The $3,143.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024 with a completion date of October 29, 2024. The award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to the U.S. government. The contract, valued at $30,363.92, was awarded by the Defense Logistics Agency (DLA) and has a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB24FU3FUDelivery Order
This federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $20,610.36, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order contract with a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is one of numerous delivery orders issued under this larger IDC. This contract award does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.6k | 2/14/24 |